Tulio Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tulio Silva has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Aitor Fernández de Larrinoa
Pathological Anatomy Service, Cruces University Hospital Osakidetza University of the Basque Country/EHU Barakaldo Spain
1 shared publication Alejandro Alegría
1 shared publication- Alfredo Guillén-Del-Castillo
Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona, Spain
1 shared publication - Bernat Gel
Hereditary Cancer Group, Program for Predictive and Personalized Medicine of Cancer - Germans Trias i Pujol Research Institute (PMPPC-IGTP), Campus Can Ruti, Badalona, Spain
1 shared publication - Claudia Valverde
University Hospital Vall d’Hebron 15 Medical Oncology Department Barcelona, Spain
1 shared publication - Cleofe Romagosa
University Hospital Vall d’Hebron 11 Pathology Department Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Fulminant cardiogenic shock complicated by SARS-CoV-2-triggered systemic capillary leak syndrome: a case report
Background: Systemic capillary leak syndrome is a rare but potentially fatal condition characterised by massive plasma extravasation into the interstitial space, leading to intravascular hypovolaemia, hypoalbuminaemia, and haemoconcentration. It can be triggered by viral infections, including SARS-CoV-2. Case summary: We present the case of a 62-year-old woman who developed fulminant SARS-CoV-2-triggered myocarditis and systemic capillary leak syndrome, with refractory cardiogenic and hypovolaemic shock. Treatment included venoarterial extracorporeal membrane oxygenation, immunosuppression, and immunoglobulins. Progressive haemoconcentration, intravascular hypovolaemia, and coagulation impairment led to a complex haemodynamic pattern that culminated in multiple organ failure and death. Discussion: This case illustrates the limitations of mechanical support in the context of systemic capillary leak syndrome, where massive third spacing with relative hypovolaemia can induce refractory venous suction and where coagulation abnormalities can lead to systemic thrombosis.
- 13 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Open AccessFulminant cardiogenic shock complicated by SARS-CoV-2-triggered systemic capillary leak syndrome: a case report
Background: Systemic capillary leak syndrome is a rare but potentially fatal condition characterised by massive plasma extravasation into the interstitial space, leading to intravascular hypovolaemia, hypoalbuminaemia, and haemoconcentration. It can be triggered by viral infections, including SARS-CoV-2. Case summary: We present the case of a 62-year-old woman who developed fulminant SARS-CoV-2-triggered myocarditis and systemic capillary leak syndrome, with refractory cardiogenic and hypovolaemic shock. Treatment included venoarterial extracorporeal membrane oxygenation, immunosuppression, and immunoglobulins. Progressive haemoconcentration, intravascular hypovolaemia, and coagulation impairment led to a complex haemodynamic pattern that culminated in multiple organ failure and death. Discussion: This case illustrates the limitations of mechanical support in the context of systemic capillary leak syndrome, where massive third spacing with relative hypovolaemia can induce refractory venous suction and where coagulation abnormalities can lead to systemic thrombosis.
- Open Access
- 26 September 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 288
Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma
- 26 September 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 288
Open AccessInflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma
- Open Access
- 17 January 2025
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 27 (1) , e13440
Peri‐Implant Epstein–Barr Virus (+) Mucocutaneous Ulcer in an Immunocompetent Patient: Case Report and Review of the Literature
Epstein–Barr virus (+) mucocutaneous ulcer (EBVMCU) is an uncommon benign lymphoproliferative lesion that develops in immunocompromised patients. We present a special case of EBVMCU located in the peri‐implant mucosa and we review the oral cases published to date. An 88‐year‐old man with no medical history of interest was attended in the dental clinic due to an ulcerated tumor located in the peri‐implant mucosa. The lesion showed an atypical lymphoid proliferation, positive for CD3, CD20, CD30, PAX‐5, and MUM1. Positive EBV and favorable patient evolution confirmed the final diagnosis of EBVMCU. Oral EBVMCU reports related to immunosenescence mainly develop in the gingiva of advanced age patients. Our case highlights the importance to perform a complete clinicopathological study of all peri‐implant lesions. Although most peri‐implant pathologies are inflammatory‐reactive disorders, sometimes they can also correspond to other entities.
- 17 January 2025
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 27 (1) , e13440
Open AccessPeri‐Implant Epstein–Barr Virus (+) Mucocutaneous Ulcer in an Immunocompetent Patient: Case Report and Review of the Literature
Epstein–Barr virus (+) mucocutaneous ulcer (EBVMCU) is an uncommon benign lymphoproliferative lesion that develops in immunocompromised patients. We present a special case of EBVMCU located in the peri‐implant mucosa and we review the oral cases published to date. An 88‐year‐old man with no medical history of interest was attended in the dental clinic due to an ulcerated tumor located in the peri‐implant mucosa. The lesion showed an atypical lymphoid proliferation, positive for CD3, CD20, CD30, PAX‐5, and MUM1. Positive EBV and favorable patient evolution confirmed the final diagnosis of EBVMCU. Oral EBVMCU reports related to immunosenescence mainly develop in the gingiva of advanced age patients. Our case highlights the importance to perform a complete clinicopathological study of all peri‐implant lesions. Although most peri‐implant pathologies are inflammatory‐reactive disorders, sometimes they can also correspond to other entities.